Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. ERYTECH Pharma S.A.
  6. News
  7. Summary
    ERYP   FR0011471135

ERYTECH PHARMA S.A.

(ERYP)
  Report
Real-time Euronext Paris  -  11:35 2022-09-28 am EDT
0.5480 EUR   -6.24%
09/28European ADRs Move Higher in Wednesday Trading
MT
09/26European ADRs Decline in Monday Trading
MT
09/23European ADRs Fall in Friday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Decline in Thursday Trading

07/28/2022 | 12:04pm EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
AMARIN CORPORATION PLC 5.31% 1.19 Delayed Quote.-64.69%
ANHEUSER-BUSCH INBEV SA/NV -0.26% 47.34 Real-time Quote.-10.96%
ARGENX SE -0.70% 366.7 Real-time Quote.16.30%
BARCLAYS PLC -3.05% 151.08 Delayed Quote.-19.21%
BICYCLE THERAPEUTICS PLC 6.46% 24.22 Delayed Quote.-60.21%
CELLECTIS S.A. 2.08% 2.55 Real-time Quote.-65.73%
DIAGEO PLC -0.89% 3823 Delayed Quote.-5.28%
ENDAVA PLC 5.96% 82.27 Delayed Quote.-51.01%
ERYTECH PHARMA S.A. -6.24% 0.548 Real-time Quote.-74.15%
GRIFOLS, S.A. -5.28% 9.082 Delayed Quote.-46.18%
INVENTIVA -2.36% 3.925 Real-time Quote.-66.57%
MIDATECH PHARMA PLC -3.03% 8 Delayed Quote.-56.16%
MORPHOSYS AG 20.16% 22.23 Delayed Quote.-33.34%
SEQUANS COMMUNICATIONS S.A. 0.00% 3.56 Delayed Quote.-24.89%
SILENCE THERAPEUTICS PLC 0.00% 2.65 Delayed Quote.0.00%
VERONA PHARMA PLC 4.49% 9.55 Delayed Quote.42.11%
All news about ERYTECH PHARMA S.A.
09/28European ADRs Move Higher in Wednesday Trading
MT
09/26European ADRs Decline in Monday Trading
MT
09/23European ADRs Fall in Friday Trading
MT
09/19ERYTECH Pharma S.A.(ENXTPA:ERYP) dropped from S&P Global BMI ..
CI
09/13Transcript : ERYTECH Pharma S.A., Q2 2022 Earnings Call, Sep 13, 2022
CI
09/12ERYTECH Provides Business and Financial Update for the First Half of 2022
GL
09/12ERYTECH Pharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
09/12ERYTECH Pharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
09/12European ADRs Climb Sharply Higher in Monday Trading
MT
09/12ERYTECH PHARMA S.A. : 1st-half-year results
CO
More news
Analyst Recommendations on ERYTECH PHARMA S.A.
More recommendations
Financials
Sales 2022 9,20 M 8,87 M 8,87 M
Net income 2022 -52,8 M -50,9 M -50,9 M
Net Debt 2022 1,50 M 1,45 M 1,45 M
P/E ratio 2022 -0,25x
Yield 2022 -
Capitalization 17,0 M 16,4 M 16,4 M
EV / Sales 2022 2,01x
EV / Sales 2023 1,39x
Nbr of Employees 149
Free-Float 98,5%
Chart ERYTECH PHARMA S.A.
Duration : Period :
ERYTECH Pharma S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ERYTECH PHARMA S.A.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus SELL
Number of Analysts 1
Last Close Price 0,55 €
Average target price 3,60 €
Spread / Average Target 557%
EPS Revisions
Managers and Directors
Gil Beyen Chief Executive Officer & Director
Eric Soyer Chief Operating & Financial Officer
Jean-Paul Kress Chairman
Iman El-Hariry Chief Medical Officer
Stewart Craig Chief Technical Officer
Sector and Competitors
1st jan.Capi. (M$)
ERYTECH PHARMA S.A.-74.15%16
GILEAD SCIENCES, INC.-11.95%78 498
REGENERON PHARMACEUTICALS, INC.11.70%74 302
VERTEX PHARMACEUTICALS33.16%73 024
BIONTECH SE-49.46%31 665
WUXI APPTEC CO., LTD.-40.29%29 141